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Abstract 
Introduction:  Oral diseases in psychiatric patients are usually a result of bad oral hygiene and psychopharmaceuti-
cal side-effects.
Objective:  The aim of this study was to detect the most prevalent oral lesions in patients hospitalized in a psychia-
tric institution in Caracas, Venezuela with the confirmed diagnosis of psychiatric illness.
Methods: A transversal study consisted of 65 hospitalized patients with psychiatric disorders out of whom 50 were 
males and 15 females. Patients were aged from 19 to 80 years, mean age 50.2 years. Data on oral lesions were 
obtained within history and clinical examination of the oral cavity. Other medical data were collected from medical 
documentation. Statistical analysis was performed by SPSS version 17.0.
Results: 56.92% of patients had caries in at least one tooth, 29.23% presented gingivitis and 56.92% periodontal 
disease. In relation to Temporomandibular joint, 36.92% presented articular sounds and 10.76% muscular pain. 
Between the most prevalent parafunctional habits were found cigarette habit, bruxism, onychophagia and cheek 
bite.
Conclusion: Results imply that psychiatric patients are more frequently involved with oral lesions than healthy 
persons. It is necessary to organize specific preventive and educational oral health programmes with these patients, 
in a multidisciplinary group.
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Introduction
Psychiatric disorders have become an increasingly fre-
quent health problem mostly affecting the elderly, repre-
senting 10% of the global load of diseases, a figure that 
is expected to reach 15% by 2020. Health professionals 
should be increasingly interested in the managing of 
such pathologies (1).
Older adults have a higher propensity to develop painful 
pathologies and dementia. With the increase of life ex-
pectancy, there has been an exponential increase in the 
number of individuals affected by dementia in the last 
few years. Several studies have indicated an incidence 
of dementia of 1% between 60 and 65 years of age, va-
lues that double every five years, until reaching 25% to 
50% at 85 years of age (2).
Mouth health is an integral part of the general health, 
and it affects all aspects of life: personal, social, and 
psychological. This is particularly important in patients 
with special needs, such as psychiatric patients (1). The-
se patients have a tendency to be more prone to develop 
bucco-dental diseases, due to their lack of motivation, 
the difficulty to perform a proper mouth health techni-
que, the hurdles that have to be overcome to treat them 
dentally, and the negative effects caused by psychotropic 
medications, affecting the normal physiology of salivary 
glands and epithelia of the oral mucous, causing xeros-
tomy or sialorrhea (3-5).
Different authors have reported that patients with men-
tal illnesses get inadequate dental care due to ignorance, 
fear, stigmas, or negative attitudes by the professionals 
(1).
Dental care in patients with mental disorders should be 
performed considering their systemic conditions, both 
of which, as already proved in the last two decades, are 
closely related. The care protocol for these patients will 
vary depending on factors such as the communication 
level that could be established with the patient, medical 
history, age, priorities in the dental treatment, prognosis, 
and future maintenance (1,6).
Patients suffering from chronic mental illness represent 
a risk group for mouth health. It has been demonstrated 
that psychiatric patients have a more frequent occurren-
ce and severity of cavities, periodontal diseases, and le-
sions of the oral mucous (7).
Medications administered for the control of signs and 
symptoms of psychiatric pathologies have well known 
side effects, all of which the specialist should be fully 
aware of, so as to avoid negative effects, since in most ca-
ses it is impossible to change the medications or dosage. 
Sedatives and anxiolytics can cause cardio-respiratory 
depression, and in some patients they cause paradoxi-
cal reactions. The only interaction with benzodiazepines 
related to dentists are the macrolides (erythromycin), as 
their mix produces an increase in the levels of serum, 
and of the half-life (8).
Material and Methods
An observational transversal study was carried out, in 
which 65 institutionalized patients were evaluated at the 
Psychiatric Center of the Venezuelan Social Security 
Institute, in Caracas. In the inclusion criteria, all patients 
with an informed consent signed by them or by their 
representative, accepting the dental evaluation, were 
considered, as well as the patients that were not aggres-
sive when allowing the clinical test. Ethical approval for 
the study was obtained from the Ethical Committee of 
the Dental School of Santa Maria University. The ages 
were between 19 and 80 years, with a 50.2 average, and 
a 51 median. The distribution in terms of gender was 15 
(23.07%) females, and 50 (76.9%) males. Once the sam-
ple was selected, the case histories of each patient were 
reviewed and the caretakers were questioned on the pre-
sence of habits, also data, such as psychiatric diagnosis 
and the medication each of them was getting, were co-
llected. In the medical diagnosis, the following patho-
logies were observed: Schizophrenia, behavioral mental 
disorders, bipolarity, organic psychosis, and dementia. 
Finally, among the families of medications consumed by 
them, anxiolytics, antipsychotics, neuroleptics, anticon-
vulsants, and antiparkinsonians were found.
To collect saliva was used the suction method of non-
stimulated saliva, 2 hours after breakfast to avoid food 
remainders. Normal non-stimulated salivary flow rate 
ranges from 0.3 to 0.5 mL/min, and flow rates between 
0.10 and 0.01 mL/min were considered hyposalivation.
A single previously calibrated operator, evaluating the 
presence of cavities, periodontal disease, oral patholo-
gies or temporomandibular joint disorders, examined 
all patients. The gingival status was assessed using the 
Löe-Silness Gingival Index (GI) and Periodontal status 
was determinated by Ramfjord Periodontal Disease In-
dex. Statistical analysis was performed by SPSS version 
17.0.
Results
In the present study, 65 patients with psychiatric disor-
ders, such as bipolarity (12.30%), psychosis (13.86%), 
dementia (10.76%), mental disorder (3.07%), and schi-
zophrenia (60%), were evaluated (Table 1). 
It was determined that 56.92% of the patients had ca-
Psychiatric diagnosis Patients Percent
Bipolarity 8 12.30%
Psychosis 9 13.86%
Dementia 7 10.76%
Mental Disorder 2 3.07%
Schizophrenia 39 60%
Table 1. Distribution of the psychiatric disorders.
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ciatina and levomepromazine); 10.76% (7  patients) 
antihypertensives (enalapril, propanolo, atenolol and 
furosemide);  38.46% (25 patients) antiparkinsonians 
(bisperiden hydrochloride and levodopa);  56.92% (37 
patients) neuroleptics (haloperidol and trifluoperazine) 
and 72.6% of the sample also consumed other types of 
medications like gastric mucosa protective agents and 
antiagregants (Table 4).
vities, and the remaining 43.08% did not have any le-
sions of this type, and that could be clinically observed. 
In terms of the periodontal disease, it was observed that 
13.84% (9 patients) of the sample did not present any 
clinical signs of periodontal disease, unlike the 29.23% 
that was diagnosed with gingivitis, and 56.92% with pe-
riodontitis. In the oral mucous evaluation were diagno-
sed 1 patient (1.5%) with melanotic pigmentation and  2 
patients (3.07%) with candidiasis that were diagnosed 
with a culture of C. albicans.
After saliva was measured was determinated that 9.2% 
of the patients presented xerostomy and 38.4% was 
diagnosed with hypersalivation.
In terms of the temporomandibular joint, 36.92% pre-
sented some joint noise. On the other hand, 26.15% of 
the sample presented a deviation in mandibular opening 
or closing. 26.15% of the patients had limitations in ope-
ning, and only 10.76% reported muscle pain on palpa-
tion (Table 2).
The case history of each patient was evaluated, and the 
Diagnosis Patients Percent
Caries 37 56.92%
Gingivitis 19 29.23%
Periodontal disease 37 56.92%
Xerostomy 6 9.23%
Hipersalivation 25 38.46%
Limitation in opening 17 26.15%
Deviation 17 26.15%
Muscle Pain 7 10.76%
Table 2. Prevalence of different pathologies in psychiatric patients.
caretakers were questioned on the presence of habits and 
was determinated that 44.6% of the patients had habits. 
It was found that 6.15% had bruxism, 27.69% smoked, 
1.53% smoked and also presented onychophagia and 
bruxism and 3.07% smoke-related bruxism, onychopha-
gia and cheilophagia (Table 3).
In terms of medications, 100% of the sample was taking 
more than one medication. 24.2% (15 patients) was ta-
king anxiolytics (diazepam); 78.46% (51 patients) an-
ticonvulsants (trileptal, valproic acid, carbamazepine, 
clonazepam and valproate semisodium); 50.76% (33 
patients) antipsychotics (olazapine, risperidone, peri-
Habit Patients Percentage
Bruxism         4 6.15%
Cigarette Smoker                         18 27.69%
Smoker + onychophagia + bruxism 1 1.53%
Smoker + onychophagia +
bruxism + cheilophagia                        
2 3.07%
Table 3. Different habits presented by the psychiatric patients.
Medication Percentage
Anxiolytics
     Diazepam                           100%
Anticonvulsivants
     Trileptal                              
     Valproic acid                      
     Carbamazepine                     
     Clonazepam                      
     Valproate semisodium        
7.84%
9.80%
62.74%
15.68%
3.92%
Antihypertensives
     Enalapril                             
     Propanolol                          
     Atenolol                              
     Furosemide                         
28.57%
28.57%
28.57%
14.28%
Antiparkinsonians
     Biperiden hydrochloride             
     Levodopa                                 
96%
4%
Antipsychotics
     Olazapine                                                
     Risperidone                          
     Periciatina                           
     Levomepromazine               
6.06%
6.06%
30.30%
48.48%
Neuroleptics
     Haloperidol                         
     Trifluoperazine                   
75.75%
24.24%
Table 4. Types of medication.
Discussion
Psychiatric patients, especially schyzophrenics, cons-
titute a risk group for periodontal diseases. Psychiatric 
factors can affect the etiopathogeny of these periodontal 
disorders. Dental hygiene is usually poor, with higher 
occurrence of plaque, and stones. The periodontopa-
thogenic plaque is more aggressive and adhesive, as a 
consequence of xerostomy and smoking (7). Clinical 
findings of this study proved that 29.23% of the patients 
presented gingivitis, 56.92% had periodontitis, and only 
13.84% of the sample did not show any signs of perio-
dontal disease. It is important to note that 78.46% of the 
patients were on anticonvulsants, which represents a 
risk factor for the development of periodontal diseases. 
Other studies, such as the one made by Gurbuz et al. (9) 
in Turkey, where 330 hospitalized patients with chronic 
psychiatric disorders were evaluated, concluded that 
only 8.8% of the patients presented healthy periodontal 
tissues. 6.3% presented gingival hemorrhage, 51.8% of 
the subjects had stones, and 33% deep periodontal sacs. 
In the same manner, Jovanovic et al. (10) evaluated 186 
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The results of this study concluded that only 9.2% of 
the patients presented xerostomy. However, 38.4% was 
diagnosed with hypersalivation.
Friedlander et al. (15) reported a detailed study of the 
effects of psychotropic medications on the buccal muco-
sa. It relates the antipsychotic agents with the occurren-
ce of dysgeusia, xerostomy, and stomatitis; benzodiaze-
pines with xerostomy and sialorrhea; mood stabilizers 
and lithium with xerostomy, and dysgeusia, and carba-
mazepine with xerostomy and glossitis.
Psychiatric disorders are a public health problem growing 
every day in larger proportions. Mouth health of these 
patients is usually more affected than the rest of the po-
pulation, as mouth hygiene is more complicated, they do 
not get enough dental care, and take several medications 
that affect the flow of saliva, and the buccal mucosa. 
For this reason, the risk of suffering from buco-dental 
diseases is very high, and thus it is necessary to create 
preventive and educational buccal health programs for 
psychiatric patients, comprised by a cross-disciplinary 
team in which the physicians treating the base disease 
play a fundamental role.
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psychiatric patients, and 186 controls in Serbia, and de-
termined that 3.3% had gingival hemorrhage, 15% den-
tal stones, and 28.3% deep sacs. Only 8.3% did not show 
any sign of periodontal disease. Another study carried 
out by Eltas et al. (11), after performing a study with 53 
psychiatric patients, with a medication which side effect 
was xerostomy or sialorrhea, concluded that there is a 
high risk for the development of periodontal disease in 
schizophrenic patients, and that such risk is even higher 
in patients that take a medication that causes a decrease 
in the flow of saliva. In terms of cavity indexes, 56.92% 
of the sample showed cavities, and 43.08% did not have 
any lesions of this kind. Similar indexes were obtained 
by Patel et al. (12), after the evaluation of 112 patients 
with mental disease, and determined that 53% of them 
had cavities in at least one of the teeth. Likewise, Kos-
sioni et al. (13), after studying a sample of 11 hospitali-
zed psychiatric patients, determined that 50.7% of them 
showed at least one cavity.
The importance of psychiatric disorders associated to 
temporomandibular disorders (TMD) has been men-
tioned in the literature, showing a relationship in the 
appearance, clinic, prognosis, and treatment of TMDs 
with psychosocial factors, such as stress, anxiety, and 
depression (7). In terms of the temporomandibular jo-
int, 36.92% presented some joint noise. Velasco-Ortega 
et al. (7) studied a sample of 50 schizophrenic patients, 
and 50 controls, and determined that 24% of schizophre-
nic patients presented joint noises. In the present study, 
26.15% of the sample showed a deviation in mandibular 
opening or closing, and 10.76% reported muscle pain on 
palpation. Most clinical studies that compare their sam-
ple to control groups have been able to determine signi-
ficant statistical differences, where study groups show a 
higher occurrence of temporomandibular disorders than 
in healthy patients. Liao et al. (14) studied a sample of 
patients suffering from depression, and a control group, 
and concluded that the occurrence of temporomandibular 
disorders was 2.65 times higher in depressed patients.
Evaluation of the oral mucous in studied patients only 
produced 2 patients (3.07%) with candidiasis, and 1 
(1.5%) with melanotic pigmentation. However, authors 
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bruxism, and cheilophagia.
Previous studies have suggested that the use of drugs 
for psychiatric treatment is a predisposing factor for 
xerostomy. Many psychotopics, such as antipsychotics, 
benzodiazepines, mood stabilizers, and antidepressants, 
cause xerostomy because they interfere with the function 
of the salivary glands. Nevertheless some antipsycotics 
like Risperidona increase the saliva’s production (1).
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